Extranodal Extension Is a Powerful Prognostic Factor in Bladder Cancer Patients with Lymph Node Metastasis - Fajkovic, Harun; Cha, Eugene K.; Jeldres, Claudio; Robinson, Brian D.; Rink, Michael; Xylinas, Evanguelos; Chromecki, Thomas F.; Breinl, Eckart; Svatek, Robert S.; Donner, Gerhard; Tagawa, Scott T.; Tilki, Derya; et al. (European urology, 2013)
Keywords: Aged; Aged, 80 and over; Biological and medical sciences; Bladder cancer; Chemotherapy, Adjuvant; Chi-Square Distribution; Cystectomy - adverse effects; Cystectomy - mortality; Europe; Extranodal extension; Female; Hematologic and hematopoietic diseases; Humans; Kaplan-Meier Estimate; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Lymph Node Excision - adverse effects; Lymph Node Excision - mortality; Lymph node metastasis; Lymph Nodes - pathology; Lymph Nodes - surgery; Lymphatic Metastasis; Male; Medical sciences; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Nephrology. Urinary tract diseases; North America; Prognosis; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Survival; Time Factors; Treatment Outcome; Tumors of the urinary system; Urinary Bladder Neoplasms - mortality; Urinary Bladder Neoplasms - pathology; Urinary Bladder Neoplasms - surgery; Urinary tract. Prostate gland; Urology; Urothelial carcinoma; North America; Europe; Lymph node metastasis; Recurrence; Prognosis; Extranodal extension; Urothelial carcinoma; Bladder cancer; Survival; Human; Nephrology; Relapse; Urinary system disease; Lymph node; Malignant lymphadenopathy; Malignant hemopathy; Urinary tract disease; Malignant tumor; Transitional cell carcinoma; Urology; Extension; Extraganglionar; Bladder disease; Cancer